Turn Therapeutics reports faster symptom relief in Phase 2 eczema trial
read at Endpoints ↗Positive readoutPositive
Turn Therapeutics, a California biotech, disclosed interim results from its Phase 2 study of a topical treatment for atopic dermatitis.
The analysis of 50 patients indicated that skin symptoms improved more rapidly than is typically observed with existing therapies, according to the company.
The company said the early data are encouraging and will guide the design of the ongoing trial and future development plans.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Turn Therapeutics' eczema drug shows rapid response in mid-stage data”
read at Endpoints ↗86 words · retrieved Jun 1
comments(0)
5-min edit window · permanent after that